{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:15:30Z","timestamp":1792512930400,"version":"4.5.0"},"reference-count":42,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018M630839"],"award-info":[{"award-number":["2018M630839"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773175"],"award-info":[{"award-number":["81773175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,10,13]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Here, we provide a feasible, well-designed protocol of a randomised controlled trial for the assessment of the effects of a home-based multidisciplinary intervention on the severity of skin adverse drug reactions and health-related indicators in patients with non-small cell lung cancer (NSCLC) under epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The study will be a two-group, parallel randomised controlled trial conducted at patients\u2019 homes by a multidisciplinary team in Zhengzhou in Henan Province, China. Patients with NSCLC who received EGFR-TKI therapy and experienced adverse skin reactions will be randomised and receive either ordinary care or home-based multidisciplinary interventions. The intervention will be divided into an intensive stage (6 weeks) and a maintenance stage (6 weeks) with baseline and follow-up assessment. Interventions in the intensive stage will include general interventions such as health education, follow-up, behaviour guide and social support and targeted interventions such as skill training, coping with adverse drug reaction and problem-solving. The measures that will be carried out in maintenance stage are continuous interventions consisted of an intensive intervention. The multidisciplinary team will be responsible for managing skin adverse drug reactions as required at patients\u2019 homes. Data collection and analysis will be performed by researchers at baseline, the end of the sixth week of intervention and the third month after the intervention. The primary outcome is the degree of skin adverse drug reactions, while the secondary outcomes, for example, self-management ability, quality of life, outpatient visits and health economics indicators, will also be presented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was reviewed and approved by the Ethics Committee of Zhengzhou University (No. ZZUIRB-2020-97). Findings will be available to patients, clinicians, nurses, pharmacists, community medical staff, funders and health policymakers through peer-reviewed publications, social media and patient support groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>Chinese Clinical Trials Registry (ChiCTR2000040643).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-063921","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T10:11:36Z","timestamp":1669630296000},"page":"e063921","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Home-based multidisciplinary interventions on skin adverse reactions in EGFR-TKI-treated patients with lung cancer: a protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-1794","authenticated-orcid":false,"given":"Ruofei","family":"Du","sequence":"first","affiliation":[{"name":"Nursing, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huashan","family":"Yang","sequence":"additional","affiliation":[{"name":"Nursing, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyue","family":"Zhou","sequence":"additional","affiliation":[{"name":"Nursing, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Statistics, Henan University of Economics and Law, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7752-4855","authenticated-orcid":false,"given":"Mikiyas Amare","family":"Getu","sequence":"additional","affiliation":[{"name":"Nursing, Zhengzhou University, Zhengzhou, Henan, China"},{"name":"Nursing, Zhengzhou University First Affiliated Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2151-7351","authenticated-orcid":false,"given":"Changying","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Nursing, Zhengzhou University, Zhengzhou, China"},{"name":"The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Nursing, Zhengzhou University, Zhengzhou, Henan, China"},{"name":"Cancer center, Telethon Kids Institute, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"2025121221581468000_12.11.e063921.1","first-page":"36","article-title":"Epidemiology of lung cancer","volume":"1","author":"Kastner","year":"2019","journal-title":"Semin Roentgenol"},{"key":"2025121221581468000_12.11.e063921.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2025121221581468000_12.11.e063921.3","first-page":"195","article-title":"Lung cancer in the young","volume":"198","author":"Nino","year":"2020","journal-title":"Lung Cancer"},{"key":"2025121221581468000_12.11.e063921.4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/cge.13511","article-title":"Difficulties and challenges in the development of precision medicine","volume":"95","author":"Liu","year":"2019","journal-title":"Clin Genet"},{"key":"2025121221581468000_12.11.e063921.5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/apjon.apjon_79_17","article-title":"Targeted therapy: attacking cancer with molecular and immunological targeted agents","volume":"5","author":"Wilkes","year":"2018","journal-title":"Asia Pac J Oncol Nurs"},{"key":"2025121221581468000_12.11.e063921.6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10120-018-0813-2","article-title":"The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials","volume":"21","author":"Zhao","year":"2018","journal-title":"Gastric Cancer"},{"key":"2025121221581468000_12.11.e063921.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3241"},{"key":"2025121221581468000_12.11.e063921.8","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.urolonc.2019.01.016","article-title":"Economic burden of renal cell carcinoma among older adults in the targeted therapy era","volume":"37","author":"Kale","year":"2019","journal-title":"Urol Oncol"},{"key":"2025121221581468000_12.11.e063921.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0804-2"},{"key":"2025121221581468000_12.11.e063921.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.5997"},{"key":"2025121221581468000_12.11.e063921.11","first-page":"651","article-title":"Dermatologic events from EGFR inhibitors: the issue of the missing patient voice","volume":"25","author":"Tischer","year":"2017","journal-title":"Support Care Cancer"},{"key":"2025121221581468000_12.11.e063921.12","first-page":"3817","article-title":"Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors","volume":"12","author":"Peng","year":"2019","journal-title":"Biosci Trends"},{"key":"2025121221581468000_12.11.e063921.13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11010-019-03677-7","article-title":"Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib","volume":"465","author":"Chmielinska","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"2025121221581468000_12.11.e063921.14","first-page":"27","article-title":"Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study","volume":"34","author":"Barrios","year":"2019","journal-title":"J Eur Acad Dermatol"},{"key":"2025121221581468000_12.11.e063921.15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/apjon.apjon_74_17","article-title":"Targeted therapy-induced facial skin toxicities: impact on quality of life in cancer patients","volume":"5","author":"Yagasaki","year":"2018","journal-title":"Asia Pac J Oncol Nurs"},{"key":"2025121221581468000_12.11.e063921.16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/jnr.0000000000000339","article-title":"SHIH H. a correlational study of skin toxicity and quality of life in patients with advanced lung cancer receiving targeted therapy","volume":"27","author":"CHAN","year":"2019","journal-title":"J Nurs Res"},{"key":"2025121221581468000_12.11.e063921.17","unstructured":"Jung L , Lee, Younhee J . Quality of life in patients with non-small cell lung cancer: structural equation modeling. Cancer Nurs. 2018."},{"key":"2025121221581468000_12.11.e063921.18","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jdv.13689","article-title":"Quality of life and disease severity in patients with atopic dermatitis","volume":"10","author":"Holm","year":"2016","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"2025121221581468000_12.11.e063921.19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12885-020-06797-2","article-title":"Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer","volume":"20","author":"Sano","year":"2020","journal-title":"BMC Cancer"},{"key":"2025121221581468000_12.11.e063921.20","first-page":"27","article-title":"Targeted molecular therapy in palliative cancer management","volume":"5","author":"Staats","year":"2020","journal-title":"Biomedicine"},{"key":"2025121221581468000_12.11.e063921.21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lungcan.2020.05.038","article-title":"Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: results from the Japanese joint Committee of lung cancer registry","volume":"146","author":"Igawa","year":"2020","journal-title":"Lung Cancer"},{"key":"2025121221581468000_12.11.e063921.22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cnur.2016.11.005","article-title":"Dermatologic reactions to targeted therapy: a focus on epidermal growth factor receptor inhibitors and nursing care","volume":"1","author":"Barton-Burke","year":"2017","journal-title":"Nurs Clin N Am"},{"key":"2025121221581468000_12.11.e063921.23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamainternmed.2018.2372","article-title":"Effect of electronic health Record-Based medication support and nurse-led medication therapy management on hypertension and medication self-management: a randomized clinical trial","volume":"178","author":"Persell","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2025121221581468000_12.11.e063921.24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/NCC.0000000000000521","article-title":"Implementation of a Nurse-driven educational program improves management","volume":"41","author":"Brunot","year":"2018","journal-title":"Cancer Nurs"},{"key":"2025121221581468000_12.11.e063921.25","first-page":"394","article-title":"Application of multidisciplinary collaborative intervention in targeted treatment of patients with advanced renal cancer at home","volume":"53","author":"Yun","year":"2019","journal-title":"Chinese Journal of Nursing"},{"key":"2025121221581468000_12.11.e063921.26","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0300-z"},{"key":"2025121221581468000_12.11.e063921.27","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1245\/s10434-016-5343-8","article-title":"The multidisciplinary approach to Gi cancer results in change of diagnosis and management of patients. multidisciplinary care impacts diagnosis and management of patients","volume":"23","author":"Meguid","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025121221581468000_12.11.e063921.28","first-page":"159-162","article-title":"Reporting of sample size parameters in randomized controlled trials published in Prosthodontic journals","volume":"28","author":"Dumbrigue","year":"2019","journal-title":"J Prosthodont"},{"key":"2025121221581468000_12.11.e063921.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2019.05.011"},{"key":"2025121221581468000_12.11.e063921.30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/pan.13330","article-title":"Understanding primary outcomes, sample size calculation, and the perils of online calculators","volume":"28","author":"Black","year":"2018","journal-title":"Paediatr Anaesth"},{"key":"2025121221581468000_12.11.e063921.31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jnu.12221","article-title":"Assessing fidelity of a community-based opioid overdose prevention program: modification of the fidelity checklist","volume":"48","author":"Clark","year":"2016","journal-title":"J Nurs Scholarsh"},{"key":"2025121221581468000_12.11.e063921.32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cnur.2016.11.005","article-title":"Dermatologic reactions to targeted therapy: a focus on epidermal growth factor receptor inhibitors and nursing care","volume":"52","author":"Barton-Burke","year":"2017","journal-title":"Nurs Clin North Am"},{"key":"2025121221581468000_12.11.e063921.33","first-page":"1082","article-title":"Development and reliability and validity of self-management scale for cancer patients","volume":"52","author":"Lingling","year":"2017","journal-title":"Chinese Journal of nursing"},{"key":"2025121221581468000_12.11.e063921.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1623-4"},{"key":"2025121221581468000_12.11.e063921.35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejon.2018.12.001","article-title":"Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: a qualitative study","volume":"38","author":"Komatsu","year":"2019","journal-title":"Eur J Oncol Nurs"},{"key":"2025121221581468000_12.11.e063921.36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Haanen","year":"2017","journal-title":"Ann Oncol"},{"key":"2025121221581468000_12.11.e063921.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2011.05.001"},{"key":"2025121221581468000_12.11.e063921.38","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12192"},{"key":"2025121221581468000_12.11.e063921.39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ad.2020.08.007","article-title":"Multidisciplinary management of the adverse effects of apremilast","volume":"112","author":"Daud\u00e9n Tello","year":"2021","journal-title":"Actas Dermosifiliogr"},{"key":"2025121221581468000_12.11.e063921.40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/bjd.15423","article-title":"Recent advances in the understanding of severe cutaneous adverse reactions","volume":"177","author":"Adler","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025121221581468000_12.11.e063921.41","first-page":"218","article-title":"Clinical criticality of pharmaceutical interventions: a multidisciplinary team scoring to improve clinical pharmacy activities efficiency","volume":"40","author":"Corny, Jennifer","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"2025121221581468000_12.11.e063921.42","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.2196\/mhealth.9363","article-title":"Development and validation of a multidisciplinary mobile care system for patients with advanced gastrointestinal cancer: interventional observation study","volume":"6","author":"Soh","year":"2018","journal-title":"JMIR Mhealth Uhealth"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-063921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:58:25Z","timestamp":1765605505000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-063921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,28]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bmjopen-2022-063921"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-063921","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}